BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 15, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

In the clinic for March 17, 2026

March 17, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Alessa, Almirall, Bayer, Biomarin, Biomea, Cytomx, Eledon, Eli Lilly, J&J, Nasus, Relay, Sarepta, Structure.
Read More

Financings for March 17, 2026

March 17, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Acumen, Alto, Biovie, JATT II, Option, Outlook, Sharp, Unnatural Products, Zenas.
Read More

Appointments and advancements for March 17, 2026

March 17, 2026
New hires and promotions in the biopharma and med-tech industries, including: Frazier, Korsana, Recludix.
Read More

Regulatory actions for March 17, 2026

March 17, 2026
Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Daiichi Sankyo, Junshi, Nanosonics, Ultragreen.ai.
Read More

Other news to note for March 17, 2026

March 17, 2026
Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: Ahngook, Aptar, Beaubrain Healthcare, C2N Diagnostics, Covirix Medical, Curatis, DT-Axis, Eli Lilly, Erasca, Fujitsu, George Medicine, Joyo, Neupharma, Prism Biolab, Receptor.AI, Takeda, Zuellig.
Read More

In the clinic for March 17, 2026

March 17, 2026
Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Ascletis, Immutep, Otsuka, Telix.
Read More

Appointments and advancements for March 17, 2026

March 17, 2026
New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Bionexus Gene Lab, Fidelion Diagnostics.
Read More

Regulatory actions for March 16, 2026

March 16, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aminex, GSK, Mineralys.
Read More

Other news to note for March 16, 2026

March 16, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AMC Robotics, Aptar, Firefly, Geovax, Hive Digital, Inovio, Insulet, Intuitive Surgical, Koelis, Oncopeptides, Pfizer, Prism, Receptor.AI, Vistagen.
Read More

In the clinic for March 16, 2026

March 16, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Beren, Immutep, Insight Molecular, Sana, Ultragenyx.
Read More
Previous 1 2 … 10 11 12 13 14 15 16 17 18 … 1781 1782 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • Cancer cell in the cross-hairs

    Selective CBL-B inhibitor with improved safety profile disclosed

    BioWorld Science
    CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing